Amarin Corp plc\uk balance sheet
At the end of fiscal 2025, Amarin Corp plc\uk had total assets of $671m, total liabilities of $211m and shareholders' equity of $459m. It held $135m in cash against $0 of debt: net cash of $135m.
Balance sheet
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 192 | 120 | 107 | 98 | 74 | 249 | 645 | 187 | 219 | 218 | 199 | 121 | 135 | 157 |
| Receivables | 4 | 8 | 14 | 20 | 45 | 67 | 116 | 155 | 164 | 131 | 134 | 122 | 127 | 112 |
| Inventory | 21 | 14 | 19 | 21 | 30 | 58 | 77 | 189 | 235 | 229 | 259 | 166 | 196 | 159 |
| Total current assets | 219 | 145 | 144 | 146 | 153 | 378 | 855 | 879 | 879 | 689 | 725 | 595 | 650 | 613 |
| Total assets | 252 | 171 | 173 | 167 | 162 | 386 | 882 | 966 | 1,068 | 886 | 832 | 685 | 671 | 634 |
| Accounts payable | 6 | 9 | 11 | 6 | 25 | 38 | 50 | 106 | 115 | 65 | 53 | 40 | 45 | 40 |
| Deferred revenue (current) | 2 | 0 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | 2 | 2 | — | — | — |
| Total current liabilities | 38 | 40 | 51 | 76 | 109 | 157 | 242 | 307 | 371 | 259 | 259 | 180 | 194 | 175 |
| Short-term debt | 13 | 15 | 12 | 16 | 22 | 34 | 50 | 0 | 0 | — | — | — | — | — |
| Long-term debt | 88 | 90 | 92 | 85 | 71 | 46 | 50 | — | — | — | — | — | — | — |
| Total debt | 101 | 105 | 104 | 101 | 93 | 80 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 286 | 260 | 301 | 176 | 227 | 233 | 274 | 339 | 401 | 291 | 280 | 199 | 211 | 190 |
| Shareholders' equity | −34 | −88 | −129 | −9 | −65 | 152 | 608 | 628 | 667 | 595 | 552 | 486 | 459 | 444 |
| Net debt (negative = net cash) | −91 | −15 | −3 | 3 | 20 | −169 | −594 | −187 | −219 | −218 | −199 | −121 | −135 | −157 |
| Shares outstanding | 9m | 9m | 9m | — | 14m | 16m | 18m | 20m | 20m | 20m | 20m | 21m | 21m | 21m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 122 | 107 | 119 | 127 | 127 | 108 | 93 | 112 |
| Inventory | 166 | 159 | 171 | 185 | 196 | 184 | 164 | 159 |
| Total current assets | 595 | 573 | 607 | 628 | 650 | 626 | 603 | 613 |
| Total assets | 685 | 656 | 670 | 660 | 671 | 646 | 624 | 634 |
| Accounts payable | 40 | 46 | 45 | 37 | 45 | 48 | 19 | 40 |
| Total current liabilities | 180 | 162 | 186 | 182 | 194 | 180 | 164 | 175 |
| Total liabilities | 199 | 182 | 205 | 201 | 211 | 196 | 181 | 190 |
| Shareholders' equity | 486 | 474 | 465 | 459 | 459 | 449 | 444 | 444 |
| Shares outstanding | 21m | 21m | 21m | 21m | 21m | 21m | 21m | 21m |
Compare with peers
- Cronos Group Inc. balance sheet
- Kamada LTD balance sheet
- Biote Corp. balance sheet
- Organigram Global Inc. balance sheet
- Heron Therapeutics, Inc. balance sheet
Head to head: AMRN vs CRONAMRN vs KMDAAMRN vs BTMDAMRN vs HRTX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies